Journal
MEDICAL CLINICS OF NORTH AMERICA
Volume 94, Issue 3, Pages 447-+Publisher
W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1016/j.mcna.2010.02.009
Keywords
Congestive heart failure; Sleep apnea; Positive airway pressure therapy; Cheyne-Stokes respiration
Categories
Funding
- Philips
- Pfizer
- NMT
- Apnex
- Cephalon
- Itamar
- Sepracor
- Restore/Medtronic
- Ethicon
- SGS
- Novartis
- American Heart Association
- NIH [HL73146, R01 HL085188-01A2, R01 HL090897-01A2, K24 HL 093218 - 01 A1]
- NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085188, K24HL093218, P01HL095491, R01HL090897, R01HL073146] Funding Source: NIH RePORTER
Ask authors/readers for more resources
Breathing disorders during sleep are common in congestive heart failure (CHF). Sleep-disordered breathing (SDB) in CHF can be broadly classified as 2 types: central sleep apnea with Cheyne-Stokes breathing, and obstructive sleep apnea. Prevalence of SDB ranges from 47% to 76% in systolic CHF. Treatment of SDB in CHF may include optimization of CHF treatment, positive airway pressure therapy, and other measures such as theophylline, acetazolamide, and cardiac resynchronization therapy. Periodic limb movements are also common in CHF.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available
Share Paper
